Literature DB >> 30445695

Modelling a Silent Epidemic: A Review of the In Vitro Models of Latent Tuberculosis.

Savannah E R Gibson1, James Harrison2, Jonathan A G Cox3.   

Abstract

Tuberculosis (TB) is the primary cause of death by a single infectious agent; responsible for around two million deaths in 2016. A major virulence factor of TB is the ability to enter a latent or Non-Replicating Persistent (NRP) state which is presumed untreatable. Approximately 1.7 billion people are latently infected with TB and on reactivation many of these infections are drug resistant. As the current treatment is ineffective and diagnosis remains poor, millions of people have the potential to reactivate into active TB disease. The immune system seeks to control the TB infection by containing the bacteria in a granuloma, where it is exposed to stressful anaerobic and nutrient deprived conditions. It is thought to be these environmental conditions that trigger the NRP state. A number of in vitro models have been developed that mimic conditions within the granuloma to a lesser or greater extent. These different models have all been utilised for the research of different characteristics of NRP Mycobacterium tuberculosis, however their disparity in approach and physiological relevance often results in inconsistencies and a lack of consensus between studies. This review provides a summation of the different NRP models and a critical analysis of their respective advantages and disadvantages relating to their physiological relevance.

Entities:  

Keywords:  Mycobacterium tuberculosis; antibiotic; drug discovery; latency; non-replicating persistent; tuberculosis

Year:  2018        PMID: 30445695      PMCID: PMC6313694          DOI: 10.3390/pathogens7040088

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  86 in total

1.  Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model.

Authors:  C Boon; R Li; R Qi; T Dick
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

2.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

Review 3.  Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting.

Authors:  Y C Manabe; W R Bishai
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

Review 4.  Tuberculosis: latency and reactivation.

Authors:  J L Flynn; J Chan
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

5.  Nitrate reduction as a marker for hypoxic shiftdown of Mycobacterium tuberculosis.

Authors:  L G Wayne; L G Hayes
Journal:  Tuber Lung Dis       Date:  1998

Review 6.  Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase.

Authors:  G C Brown
Journal:  Biochim Biophys Acta       Date:  2001-03-01

7.  Bactericidal activity of nitrofurans against growing and dormant Mycobacterium bovis BCG.

Authors:  B Murugasu-Oei; T Dick
Journal:  J Antimicrob Chemother       Date:  2000-12       Impact factor: 5.790

8.  Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection.

Authors:  R Hernández-Pando; M Jeyanathan; G Mengistu; D Aguilar; H Orozco; M Harboe; G A Rook; G Bjune
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

9.  Differential expression of 10 sigma factor genes in Mycobacterium tuberculosis.

Authors:  R Manganelli; E Dubnau; S Tyagi; F R Kramer; I Smith
Journal:  Mol Microbiol       Date:  1999-01       Impact factor: 3.501

10.  Assessment of immunity to mycobacterial infection with luciferase reporter constructs.

Authors:  V A Snewin; M P Gares; P O Gaora; Z Hasan; I N Brown; D B Young
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

View more
  7 in total

1.  A Universal Stress Protein That Controls Bacterial Stress Survival in Micrococcus luteus.

Authors:  Spencer Havis; Abiodun Bodunrin; Jonathan Rangel; Rene Zimmerer; Jesse Murphy; Jacob D Storey; Thinh D Duong; Brandon Mistretta; Preethi Gunaratne; William R Widger; Steven J Bark
Journal:  J Bacteriol       Date:  2019-11-20       Impact factor: 3.490

Review 2.  Immune Response to Mycobacterium tuberculosis: A Narrative Review.

Authors:  Maurizio de Martino; Lorenzo Lodi; Luisa Galli; Elena Chiappini
Journal:  Front Pediatr       Date:  2019-08-27       Impact factor: 3.418

Review 3.  Addressing Latent Tuberculosis: New Advances in Mimicking the Disease, Discovering Key Targets, and Designing Hit Compounds.

Authors:  André Campaniço; Shrika G Harjivan; Digby F Warner; Rui Moreira; Francisca Lopes
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

4.  Iron deprivation enhances transcriptional responses to in vitro growth arrest of Mycobacterium tuberculosis.

Authors:  Sogol Alebouyeh; Jorge A Cárdenas-Pestana; Lucia Vazquez; Rafael Prados-Rosales; Patricia Del Portillo; Joaquín Sanz; Maria Carmen Menéndez; Maria J García
Journal:  Front Microbiol       Date:  2022-10-04       Impact factor: 6.064

5.  Estimation of the mutation rate of Mycobacterium tuberculosis in cases with recurrent tuberculosis using whole genome sequencing.

Authors:  Jessica Comín; Alberto Cebollada; Sofía Samper
Journal:  Sci Rep       Date:  2022-10-06       Impact factor: 4.996

6.  Treatment of Granulomatous Mastitis: Is There a Role for Antibiotics?

Authors:  Meagan S Williams; Adelaide H McClintock; Lori Bourassa; Mary B Laya
Journal:  Eur J Breast Health       Date:  2021-06-24

Review 7.  Targeting Non-Replicating Mycobacterium tuberculosis and Latent Infection: Alternatives and Perspectives (Mini-Review).

Authors:  Anna Egorova; Elena G Salina; Vadim Makarov
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.